logo

For the Inventor, By the Inventor

Rumst, Belgium

Eddy J Freyne

USPTO Granted Patents = 30

Average Co-Inventor Count = 3.3

ph-index = 8

Forward Citations = 207(Granted Patents)


Company Filing History:

goldMedal29 out of 2,079 
 
Janssen Pharmaceutica Nv
 patents
silverMedal1 out of 1 
 
Hanssen Pharmaceutica
 patent

Years Active: 1988-2015

Loading Chart...
30 patents (USPTO):Explore Patents
1. 8933067 - Pyrido and pyrimidopyrimidine derivatives as anti-profilerative agents (2015-01-13),
2. 6656959 - PDE IV inhibiting pyridine derivatives (2003-12-02),
3. 6051718 - PDE IV inhibiting 2-cyanoiminoimidazole derivatives (2000-04-18),
4. 5994376 - 1,3-dihydro-1-(phenylalkyl)-2H-imidazol-2-one compounds and their use (1999-11-30),
5. 5952510 - 1,3-dihydro-1-(phenylalkenyl)-2H-imidazol-2-one derivatives having PDE (1999-09-14),
6. 5869515 - 1,3-dihydro-2H-imidazol-2-one compounds (1999-02-09),
7. 5612354 - (1H-azol-1-ylmethyl)substituted quinoline derivatives (1997-03-18),
8. 5602134 - Positive inotropic and lusitropic pyrroloquinolinone derivatives (1997-02-11),
9. 5541325 - Intermediates for the preparation of (1996-07-30),
10. 5521187 - 1,3-Dihydro-2H-imidazo[4,5-B]quinolin-2-one derivatives (1996-05-28),
11. 5516908 - 1,3-dihydro-2H-imidazo-[4,5-.beta.]quinolin-2-one derivatives and (1996-05-14),
12. 5491161 - Pyrroloimidazolyl and imidazopyridinyl substituted 1H-benzimidazole (1996-02-13),
13. 5457102 - Pyrroloimidazolyl and imidazopyridinyl substituted 1H-benzimidazole (1995-10-10),
14. 5441954 - (1h-azol-1-ylmethyl) substituted quinoline derivatives (1995-08-15),
15. 5268380 - (1H-azol-1-ylmethyl) substituted quinoline derivatives (1993-12-07),

As an AI assistant specializing in innovations, inventions, inventors, patent attorneys, assignees, and patents, I can provide you with the comprehensive article about inventor Eddy J Freyne. Here it is:

Title: Unveiling the Innovations of Eddy J Freyne: A Prolific Inventor from Rumst, Belgium

Introduction:

Eddy J Freyne, a distinguished inventor hailing from Rumst, Belgium, has made significant contributions to the field of pharmaceuticals with a remarkable portfolio of 30 patents. His groundbreaking work has not only propelled scientific advancements but has also touched numerous lives through his innovative inventions.

Latest Patents:

Among his latest patents, Eddy J Freyne has introduced pioneering compounds such as Pyrido and Pyrimidopyrimidine derivatives as anti-proliferative agents, demonstrating his expertise in developing novel pharmaceutical solutions. Additionally, his work on PDE IV inhibiting pyridine derivatives showcases his commitment to advancing the realm of medicine through cutting-edge research.

Career Highlights:

Having worked with esteemed companies like Janssen Pharmaceutica NV and Hanssen Pharmaceutica, Eddy J Freyne has garnered extensive experience and knowledge in the pharmaceutical industry. His tenure with these organizations has been marked by numerous breakthroughs and innovative discoveries that have reshaped the landscape of medicine.

Collaborations:

Throughout his career, Eddy J Freyne has collaborated with notable colleagues such as Alfons H Raeymaekers and Marc Gaston Venet, pooling their expertise and insights to drive collaborative research projects and amplify the impact of their inventions. These partnerships have been instrumental in fostering a culture of innovation and excellence in the scientific community.

Conclusion:

In conclusion, Eddy J Freyne stands as a beacon of innovation in the field of pharmaceuticals, with a remarkable track record of 30 patents and a legacy of transformative inventions. His unwavering dedication to scientific advancement and his collaborative spirit have solidified his position as a pioneer in the realm of inventors, leaving an indelible mark on the world of medicine.

If you require further details or have any specific inquiries regarding Eddy J Freyne or any other inventor, feel free to reach out.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…